Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PTCT
#2722
PTC Therapeutics, Inc. - Common Stock
81.3
3
USD
-0.04%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-4.15%
Monthly Change
+12.91%
6 month change
+5.23%
Year Change
+64.50%
Previous Close
84.8
5
Open
81.3
3
Low
81.3
3
High
81.3
3
Volume
187
Markets
US Stock Market
Healthcare
Biotechnology
PTCT
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
70.32 M
71.36 M
73.82 M
76.61 M
78.87 M
82.77 M
8.29 M
Valuation ratios
Enterprise value
4.39 B
3.09 B
3.11 B
1.84 B
3.07 B
5.59 B
-135.38 M
Price to earnings ratio
—
-5.36
-4.9
-3.35
-9.54
9.76
-36.78
Price to sales ratio
—
5.21
3.92
2.24
4.3
3.88
8.53
Price to cash flow ratio
—
-11.17
7.67
13.25
32.21
9.43
-32.26
Price to book ratio
—
1 951.79
7.89
2.56
3.16
-32.67
-9.42
Enterprise value to EBITDA ratio
-11.3
-9.88
-9.72
-8.55
-12.78
6.53
9.13
Profitability ratios
Return on assets %
-0.2
-0.27
-0.33
-0.33
-0.21
0.24
-0
Return on equity %
-0.91
-364.33
1.61
0.77
0.33
-3.32
0.02
Return on invested capital %
-163.09
-133.73
-147.95
-159.37
-160.82
280.38
16.83
Gross margin %
99.87
99.59
99.76
98.67
98.36
99.7
99.34
Operating margin %
-113.39
-69.52
-64.03
-46.86
-37.5
50.09
16.5
EBITDA margin %
-102.1
-58.02
-45.83
-22.97
-29.76
52.04
21.49
Net margin %
-115.07
-97.27
-80
-66.81
-45.03
39.44
-1.03
Liquidity ratios
Quick ratio
4.37
1.84
1.65
1.97
2.31
2.27
2.36
Current ratio
4.44
1.87
1.71
2.02
2.35
2.35
2.44
Inventory turnover
0.03
0.13
0.09
0.48
0.49
0.07
0.02
Asset turnover
0.2
0.26
0.38
0.52
0.45
0.6
0.09
Solvency ratios
Debt to assets ratio
0.14
0.15
0.34
0.15
0.17
0.1
—
Debt to equity ratio
0.64
196.03
-1.65
-0.35
-0.26
-1.39
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-3.57
-4.97
-2.12
-1.4
8.05
-2.61
EBIT per share
—
-5.35
-6.26
-6.04
-4.11
9.76
-0.72
EBITDA per share
—
-4.43
-4.47
-2.88
-3.12
10.2
-0.16
Total debt per share
—
6.17
8.01
3.84
3.75
3.23
—
Cash per share
—
10.98
5.73
11.72
14.83
22.03
22.93
Net current asset value per share
—
13.54
9.67
16.28
17.77
25.75
27.31
Tangible book value per share
—
0.02
-4.84
-10.94
-14.29
-2.32
-2.19
Working capital per share
—
6.32
4.01
8.22
10.21
14.78
16.12
Book value per share
—
0.02
-4.84
-10.94
-14.29
-2.32
-2.19
News
Macro Note: The Tech Unwind Grew A Second Leg, And It’s Healthcare
Reasons Why Investors Should Consider Betting on PTC Stock Now
Immunome Stock Up 32% in a Month: Here's What You Should Know
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN
Agilent Strengthens Biopharma Growth Prospects With AI Expansion
Stocks Look Shaky, But This Sector is Booming (Biotech)
PTC Therapeutics (PTCT) Upgraded to Strong Buy: Here's What You Should Know
CPRX's Agamree Shows Potential Beyond DMD After Positive Phase I Data
Can Biogen's New Drugs Revive Growth Amid Legacy Sales Slump?
PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last?
Leqembi Isn’t Enough To Save Biogen Momentum (NASDAQ:BIIB)
KROS Turns to Next Wave of TGF-Beta Muscle Therapies